Clinical Trial Update: To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial compared pharmacokinetics, efficacy, and safety of CT-P17 with Humira in adults with moderate to severe chronic plaque psoriasis. The study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CT-P17 (adalimumab biosimilar)
• Humira (adalimumab)

Snippet

Sponsor: Celltrion | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED